Abstract
Aim:
The present study was conducted to investigate whether alpha-lipoic acid (α-LA) is able to reverse impaired bladder function induced by diabetes in a rat model and to explore the possible mechanism mediating the effect.
Methods:
Male Sprague-Dawley rats were divided randomly into 3 age-matched groups: control, diabetes mellitus (DM) treated with vehicle, and DM with α-LA treatment. The diabetic rats were induced by a single intraperitoneal (ip) injection of streptozotocin (60 mg/kg). Six weeks after the induction of DM, the two groups received another 6 weeks of treatment with vehicle or α-LA (100 mg/kg, ip). Body weight and blood glucose levels were measured weekly. The bladder function was evaluated by in vitro cystometry. The oxidative stress status was determined by biochemical methods, and the level of nerve growth factor was investigated by enzyme-linked immunosorbent assay.
Results:
The streptozotocin-induced diabetic rats showed impaired bladder function characterized by increased bladder capacity, decreased bladder contractility (voiding efficiency), and an increase in residual urine. Treatment with α-LA significantly normalized the increased bladder capacity for inducing voiding, single-voided volume, and post-void residual volume. α-LA treatment significantly reversed the increased level of malondialdehyde and reduced the activities of both superoxide dismutase and catalase. DM caused a decrease in the bladder nerve growth factor (NGF) level, and α-LA upregulated the level of NGF in the diabetic rat bladder.
Conclusion:
These results indicate that α-LA has a beneficial effect on diabetes-induced cystopathy by ameliorating oxidative stress and normalizing the NGF level in the bladder.
Similar content being viewed by others
Article PDF
References
Brown JS, Wessells H, Chancellor MB, Howards SS, Stamm WE, Stapleton AE, et al. Urologic complications of diabetes. Diabetes Care 2005; 28: 177–85.
Yoshimura N, Chancellor MB, Andersson KE, Christ GJ . Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 2005; 95: 733–8.
Bradley WE . Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 1980; 92: 323–6.
Ueda T, Yoshimura N, Yoshida O . Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 1997; 157: 580–4.
Sasaki K, Chancellor MB, Phelan MW, Yokoyama T, Fraser MO, Seki S . Diabetic cystopathy correlates with long-term decrease in nerve growth factor (NGF) levels in the bladder and lumbosacral dorsal root ganglia. J Urol 2002; 168: 1259–64.
Sen CK, Packer L . Thiol homeostasis and supplements in physical exercise. Am J Clin Nutr 2000; 72: S653–69.
Packer L, Kraemer K, Rimbach G . Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001; 17: 888–95.
Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C . Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney. Kideny Int 2005; 67: 1371–80.
Shotton HR, Broadbent S, Lincoln J . Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoid acid and evening primrose oil. Auton Neurosci 2004; 111: 57–65.
Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365–70.
Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with α-lipoid acid: the SYDNEY trial. Diabetes Care 2003; 26: 770–6.
Zini A, de Lamirande E, Gagnon C . Reactive oxygen species in semen of infertile patients: level of superoxide dismutase- and catalase-like activities in seminal plasma and spermatozoa. Int J Androl 1993; 16: 183–8.
Maritim AC, Sanders RA, Watkins JB III . Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17: 24–38.
Brownlee M . The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615–25.
Niedowicz DM, Daleke DL . The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43: 289–330.
Beshay E, Carrier S . Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 2004; 64: 1062–7.
Baydas G, Canatan H, Turkoglu A . Comparative analysis of the protective effects of melatonin and vitamin E on streptozocin-induced diabetes mellitus. J Pineal Res 2002; 32: 225–30.
Sena CM, Nunes E, Louro T, Proenca T, Seica RM . Endothelial dysfunction in type 2 diabetes: effect of antioxidants. Rev Port Cardiol 2007; 26: 609–19.
Halliwell B, Chiricos S . Lipid peroxidation: its mechanism, measurements and significance. Am J Clin Nut 1993; 57: S715–25.
Kakkar R, Kalra J, Mantha SV, Prasad K . Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 1995; 151: 113–9.
Tong YC, Cheng JT . Changes in bladder nerve-growth factor and p75 genetic expression in streptozotocin-induced diabetic rats. BJU Int 2005; 96: 1392–6.
Steinbacher BC, Nadelhaft I . Increased levels of nerve growth factor in the urinary bladder and hypertrophy of dorsal root ganglion neurons in the diabetic rat. Brain Res 1998; 782: 255–60.
Steers WD, Tuttle JB . Mechanisms of disease: the role of nerve growth factor in the pathophysiology of bladder disorders. Nat Clin Pract Urol 2006; 3: 101–10.
Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H, et al. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol 2001; 165: 1748–54.
Sasaki K, Chancellor MB, Goins WF, Phelan MW, Glorioso JC, de Groat WC, et al. Gene therapy using replication-defective herpes simplex virus vectors expressing nerve growth factor in a rat model of diabetic cystopathy. Diabetes 2004; 53: 2723–30.
Smith AR, Shenvi SV, Widlansky M, Suh JH, Hagen TM . Lipoic acid as a potential therapy for chronic diseases associated with oxidative stress. Curr Med Chem 2004; 11: 1135–46.
Garrett NE, Malcangio M, Dewhurst M, Tomlinson DR . alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support. Neurosci Lett 1997; 222: 191–4.
Li XM, Juorio AV, Qi J, Boulton AA . L-Deprenyl potentiates NGF-induced changes in superoxide dismutase mRNA in PC12 cell. J Neurosci Res 1998; 53: 235–38.
Ceriello A . Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 2006; 17: 510–8.
Da Ros R, Assaloni R, Ceriello A . Molecular targets of diabetic vascular complications and potential new drugs. Curr Drug Targets 2005; 6: 503–9.
Saito M, Wada Y, Ikeda K, Wang Z, Smith SD, Foster HE, et al. Gene expression, localization, and pharmacological characterization of endothelin receptors in diabetic rat bladder dome. Eur J Pharmacol 2000; 387: 253–63.
Poladia DP, Bauer JA . Early cell-specific changes in nitric oxide synthases, reactive nitrogen species formation, and ubiquitinylation during diabetes-related bladder remodeling. Diabetes Metab Res Rev 2003; 19: 313–9.
Gouty S, Regalia J, Cai F, Helke CJ . Alpha-lipoic acid treatment prevents the diabetes-induced attenuation of the afferent limb of the baroreceptor reflex in rats. Auton Neurosci 2003; 108: 32–4.
Saito M, Kinoshita Y, Satoh I, Shinbori C, Suzuki H, Yamada M, et al. Ability of cyclohexenonic long-chain fatty alcohol to reverse diabetes-induced cystopathy in the rat. Eur Urol 2007; 51: 479–87.
Torimoto K, Hirao Y, Matsuyoshi H, de Groat WC, Chancellor MB, Yoshimura N . alpha1-Adrenergic mechanism in diabetic urethral dysfunction in rats. J Urol 2005; 173: 1027–32.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by a grant from the Education Department of Liaoning Province (No 05L552).
Rights and permissions
About this article
Cite this article
Jiang, Yj., Gong, Dx., Liu, Hb. et al. Ability of alpha-lipoic acid to reverse the diabetic cystopathy in a rat model. Acta Pharmacol Sin 29, 713–719 (2008). https://doi.org/10.1111/j.1745-7254.2008.00790.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00790.x
Keywords
This article is cited by
-
Established and emerging treatments for diabetes-associated lower urinary tract dysfunction
Naunyn-Schmiedeberg's Archives of Pharmacology (2022)
-
Daidzein attenuates urinary bladder dysfunction in streptozotocin-induced diabetes in rats by NOX-4 and RAC-1 inhibition
Naunyn-Schmiedeberg's Archives of Pharmacology (2022)
-
Antagonism of proNGF or its receptor p75NTR reverses remodelling and improves bladder function in a mouse model of diabetic voiding dysfunction
Diabetologia (2020)
-
Alpha-lipoic acid preserves the structural and functional integrity of red blood cells by adjusting the redox disturbance and decreasing O-GlcNAc modifications of antioxidant enzymes and heat shock proteins in diabetic rats
European Journal of Nutrition (2012)
-
Pygeum africanum: effect on oxidative stress in early diabetes-induced bladder
International Urology and Nephrology (2010)